Anton G T Terwisscha van Scheltinga Selected Research

Anton G T Terwisscha van Scheltinga Research Topics

Disease

21	Neoplasms (Cancer) 01/2020 - 11/2011
3	Breast Neoplasms (Breast Cancer) 11/2017 - 01/2017
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 01/2018
2	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 11/2012
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017 - 12/2015
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Rectal Neoplasms (Rectal Cancer) 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2017
1	Mesothelioma 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 05/2016
1	Leukemia 01/2016
1	Bites and Stings (Sting) 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2016
1	Triple Negative Breast Neoplasms 09/2014
1	Atherosclerotic Plaque (Atheroma) 06/2013
1	Esophageal Neoplasms (Esophageal Cancer) 06/2013

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 03/2019 - 06/2013
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2017 - 11/2011
4	ErbB Receptors (EGF Receptor)IBA 10/2017 - 10/2016
4	Bevacizumab (Avastin)FDA Link 01/2017 - 11/2011
3	Proteins (Proteins, Gene)FDA Link 11/2017 - 11/2012
3	Zirconium-89IBA 11/2017 - 07/2014
3	Monoclonal AntibodiesIBA 10/2017 - 10/2016
3	Immunoconjugates (Immunoconjugate)IBA 01/2017 - 12/2015
3	89Zr-bevacizumabIBA 06/2013 - 11/2012
2	human ERBB2 proteinIBA 11/2017 - 11/2011
2	Tyrosine Kinase InhibitorsIBA 11/2017 - 08/2017
2	lumretuzumabIBA 10/2017 - 07/2014
2	monomethyl auristatin EIBA 01/2017 - 05/2016
2	MesothelinIBA 01/2017 - 12/2015
2	Fluorescent Dyes (Fluorescent Probes)IBA 01/2017 - 01/2016
2	IRDye 800CWIBA 01/2016 - 12/2015
2	Biomarkers (Surrogate Marker)IBA 07/2014 - 11/2012
1	Peptides (Polypeptides)IBA 01/2020
1	IntegrinsIBA 01/2020
1	Lapatinib (GW572016)FDA Link 11/2017
1	LigandsIBA 08/2017
1	onartuzumabIBA 08/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2017
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 08/2017
1	89Zr-MSB0010853IBA 01/2017
1	Epithelial Cell Adhesion MoleculeIBA 01/2016
1	Differentiation AntigensIBA 12/2015
1	AntigensIBA 12/2015
1	Insulin-Like PeptidesIBA 09/2014
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 09/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2014
1	Dihydrotachysterol (AT 10)IBA 04/2014
1	PRS-110IBA 04/2014
1	zirconium-89-trastuzumabIBA 06/2013
1	MTOR InhibitorsIBA 11/2012
1	Everolimus FDA Link 11/2012
1	AntibodiesIBA 11/2011
1	Trastuzumab (Herceptin)FDA Link 11/2011

Therapy/Procedure

2	Therapeutics 01/2017 - 11/2012
1	Neoadjuvant Therapy 01/2020
1	Castration 05/2016
1	Intravenous Administration 01/2016
1	Aftercare (After-Treatment) 06/2013